Sugi Predict

Sugi Predict / Compounds / SCHEMBL26952437

SCHEMBL26952437

SCHEMBL26952437

CCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCCCC1NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)CC(C)C)[C@@H](C)O)CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(N)=O)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]2CCCN2C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc2ccccc2)NC1=O)C(=O)O

nearest known ligand 0.59

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ MC4R P32245 2/20 0.59
▸ MC1R Q01726 2/20 0.59
▸ NPY2R P49146 12/20 0.58
▸ MC3R P41968 1/20 0.58
▸ CSNK2A2 P19784 1/20 0.57
▸ CSNK2B P67870 1/20 0.57
▸ CSNK2A1 P68400 1/20 0.57
▸ CSNK2A3 Q8NEV1 1/20 0.57
▸ GLP1R P43220 2/20 0.55
▸ GCGR P47871 2/20 0.55
▸ INSR P06213 1/20 0.55
▸ F11 P03951 1/20 0.54
▸ TEAD1 P28347 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20402542 0.93 MC4R (0.53) MC4RMC1RNPY2RMC3RCSNK2A2
SCHEMBL20003972 0.93 MC4R (0.53) MC4RMC1RNPY2RMC3RCSNK2A2
SCHEMBL23056722 0.93 TEAD1 (0.53) MC4RMC1RNPY2RMC3RCSNK2A2
SCHEMBL27014090 0.93 TEAD1 (0.53) MC4RMC1RNPY2RMC3RCSNK2A2
SCHEMBL20003971 0.91 GLP1R (0.51) MC4RMC1RNPY2RMC3RGLP1R
SCHEMBL20003981 0.91 MC4R (0.50) MC4RMC1RNPY2RMC3RCSNK2A2
SCHEMBL23056750 0.89 GLP1R (0.51) MC4RMC1RNPY2RGLP1RGCGR
SCHEMBL20003753 0.85 PRLHR (0.58) NPY2RGLP1RGCGR
SCHEMBL26292602 0.80 RAMP3 (0.49) NPY2RCSNK2A2CSNK2BCSNK2A1CSNK2A3
SCHEMBL29394223 0.79 INSR (0.62) MC4RMC1RNPY2RMC3RCSNK2A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240016895-A1 HEPCIDIN MIMETICS FOR TREATMENT OF SICKLE CELL DISEASE PROTAGONIST THERAPEUTICS, INC. 2024-01-18 — — US disclosed
WO-2023240077-A1 HEPCIDIN MIMETICS FOR TREATMENT OF SICKLE CELL DISEASE PROTAGONIST THERAPEUTICS, INC. (US) 2023-12-14 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240016895-A1 HEPCIDIN MIMETICS FOR TREATMENT OF SICKLE CELL DISEASE HAMP, HBG1, HBG2 MC4R 1409/4885MC1R 487/4885NPY2R 1042/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.